Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer

The natural history of radiorecurrent high-risk prostate cancer (HRPCa) is not well-described. To better understand its clinical course, we evaluated rates of distant metastases (DM) and prostate cancer-specific mortality (PCSM) in a cohort of 978 men with radiorecurrent HRPCa who previously receive...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European urology 2021-08, Vol.80 (2), p.142-146
Hauptverfasser:	Philipson, Rebecca G., Romero, Tahmineh, Wong, Jessica K., Stish, Bradley J., Dess, Robert T., Spratt, Daniel E., Pilar, Avinash, Reddy, Chandana, Wedde, Trude B., Lilleby, Wolfgang A., Fiano, Ryan, Merrick, Gregory S., Stock, Richard G., Demanes, D. Jeffrey, Moran, Brian J., Braccioforte, Michelle, Tran, Phuoc T., Martin, Santiago, Martinez-Monge, Rafael, Krauss, Daniel J., Abu-Isa, Eyad I., Valle, Luca, Chong, Natalie, Pisansky, Thomas M., Choo, C. Richard, Song, Daniel Y., Greco, Stephen, Deville, Curtiland, McNutt, Todd, DeWeese, Theodore L., Ross, Ashley E., Ciezki, Jay P., Tilki, Derya, Karnes, R. Jeffrey, Klein, Eric A., Tosoian, Jeffrey J., Boutros, Paul C., Nickols, Nicholas G., Bhat, Prashant, Shabsovich, David, Juarez, Jesus E., Kupelian, Patrick A., Rettig, Matthew B., Berlin, Alejandro, Tward, Jonathan D., Davis, Brian J., Reiter, Robert E., Steinberg, Michael L., Elashoff, David, Horwitz, Eric M., Tendulkar, Rahul D., Kishan, Amar U.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biochemical recurrence Brachytherapy - adverse effects Brachytherapy boost EBRT External beam radiation therapy High-risk prostate cancer Humans Male Neoplasm Grading Prostate Prostate cancer Prostatic Neoplasms - radiotherapy Radiorecurrence Recurrent prostate cancer Salvage Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!